MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 144 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 2.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,763,000 | -37.1% | 277,641 | -15.7% | 0.01% | -61.8% |
| Q3 2015 | $2,803,000 | -54.1% | 329,361 | -33.4% | 0.03% | -57.5% |
| Q2 2015 | $6,112,000 | +294.1% | 494,325 | +179.8% | 0.08% | +263.6% |
| Q3 2014 | $1,551,000 | +174.0% | 176,647 | +127.7% | 0.02% | +175.0% |
| Q2 2014 | $566,000 | – | 77,585 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,244,080 | $12,096,000 | 4.51% |
| ALTFEST L J & CO INC | 39,491 | $1,653,000 | 1.15% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $446,000 | 0.44% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,074,557 | $48,912,000 | 0.40% |
| Virtus ETF Advisers LLC | 87,477 | $472,000 | 0.35% |
| Cannell & Co. | 1,614,678 | $8,703,000 | 0.32% |
| Birchview Capital, LP | 44,000 | $237,000 | 0.17% |
| STONERIDGE INVESTMENT PARTNERS LLC | 180,534 | $973,000 | 0.14% |
| HighPoint Advisor Group LLC | 8,484 | $344,000 | 0.12% |
| MARINER INVESTMENT GROUP LLC | 63,090 | $340,000 | 0.12% |